$1.5M sweet spot round size
Most of their 15 investments are in rounds between $8.1M and $20M
Kupando GmbH raised $13M on September 26, 2022
Investors: Brandenburg Kapital GmbH, High-Tech Gründerfonds and Remiges Ventures, Inc.
Immunis, Inc. raised $10M on August 3, 2022
Investors: Continuum Health Ventures and Remiges Ventures, Inc.
LUCA Science Inc. raised $30M on June 6, 2022
Investors: SMBCベンチャーキャピタル(株), 旭化成ファーマ(株), ニッセイ・キャピタル(株), NVCC, Fast Track Initiative and Remiges Ventures, Inc.
Restore Vision raised $2.6M on February 3, 2022
Investors: ANRI and Remiges Ventures, Inc.
Capacity Bio raised undisclosed on January 1, 2022
Investors: Remiges Ventures, Inc.
Glycomine Inc. raised $35M on June 23, 2021
Investors: Chiesi Ventures, RiverVest Venture Partners, Sanofi Ventures, Mission BioCapital, Abingworth, Novo Holdings and Remiges Ventures, Inc.
Cyrano Therapeutics raised $13M on December 10, 2020
Investors: Lumira Ventures and Remiges Ventures, Inc.
LUCA Science Inc. raised $9.8M on September 1, 2020
Investors: (株)カーク, Axil Capital Partners, Axil Capital Advisors K.K., Fast Track Initiative, NVCC and Remiges Ventures, Inc.
Tranquis Therapeutics, Inc. raised $30M on July 9, 2020
Investors: Correlation Ventures, Vivo Capital, S.R. One Ltd and Remiges Ventures, Inc.
OMEICOS Therapeutics GmbH raised $19M on November 2, 2018
Investors: KG Investments, LLC, Vesalius Biocapital, KfW, Forbion, High-Tech Gründerfonds and Remiges Ventures, Inc.